Do long-term risks of gray-market peptides worry you?
- Thread starter Drehimpuls
- Start date
BNLFL
Explorer
To be honest, I have never really picked up on him. In fact, I have cut back quite a bit on the wise-ass remarks.
Your sense of humor has always been something I appreciate..
That said, plenty of my friends are older, grumpy neighbors!
My lawn is open to you.
BUT DON'T PARK THERE!
Then again, I might be one of those cranky types too..
GeekyGirl
Explorer
Not in the slightest. For one thing, plenty of products sail through FDA approval and later turn out to cause all SORTS of harm — more than should ever happen. That stamp of approval doesn't impress me much anymore. For another, the excess weight I've been carrying comes with its own health issues, and I'm working on fixing those. On top of that, I've already outlived the age my mom was when she died, and I've inherited a whole pile of frightening conditions from my parents. I can't spend my energy dreading what might come later when none of us were ever promised a future anyway. I'm doing the best I can with whatever knowledge I can get my hands on. No point in stressing over maybe.
bamagirl26
Explorer
The gray aspect doesn't really bother me. What I do think about now and then is what the very LONNNNNNG term might do. Then again, that applies to plenty of things. Right now I like the way these make me feel, and if a point arrives when I can hold my weight without the drugs, I'll stop for a while? All I know is that I'm losing at the moment and I'm happy about that. The inflammation in my joints has gotten much better too,
No. Compared with random supplements I pick up on Amazon, I actually feel safer about gray (testing, procedure) — those capsules could be full of sawdust for all I know! And since I spent most of my life as a nicotine user and willingly breathed in poison (17 days quit!), gray barely registers as a worry. Set against microplastics, environmental carcinogens, doing construction without masks, and stress… gray is probably among the safest things I do.
If insurance covered Zepbound I'd go that route, but it doesn't, so I won't — and I'm happy to take gray!
If insurance covered Zepbound I'd go that route, but it doesn't, so I won't — and I'm happy to take gray!
Just A Cat
Explorer
What frightens me more is the damage that unchecked metabolic dysfunction could inflict on my body, along with the hit that paying for the brand-name medication out of pocket would take on my finances.
Honestly, tiny amino acids and whatever contaminants might be in them aren't high on my list of concerns—I've got bigger things to stress about. At 34, I'm already well into middle age given my family's history of heart problems, and I was diagnosed with a heart disorder back in my early 20s.
On top of that, my job exposes me to chemicals that are well documented as cancer-causing and organ-damaging. So if my heart doesn't finish me off, there's a pretty solid chance those chemicals will.
On top of that, my job exposes me to chemicals that are well documented as cancer-causing and organ-damaging. So if my heart doesn't finish me off, there's a pretty solid chance those chemicals will.
lessthanhalf
Explorer
Tirzepatide itself, when used over a longer period, lowers the odds of death from any cause (among people who already have heart disease or diabetes). That is about as strong a signal as you can get that the benefits outweigh the harms, and realistically the likelihood of long-term harm looks very low — so low that many of these issues are genuinely difficult to prove, since they are rare and hard to reach statistical significance on things like NAION or pancreatic cancer. Meanwhile the roster of beneficial effects — some better established than others, and some only in certain groups — is large and still expanding.
With the grey versions in particular, the worries center on contaminants, whether toxic or carcinogenic, on peptide fragments, or on bacterial or fungal contamination. Mislabelling and misdosing are the other concerns. Infections from grey peptide use appear quite uncommon on this forum. From what I have read, peptide breakdown fragments are unlikely to be a problem because they have a very short half-life in the body; that leaves toxic residue from poor manufacturing or cleaning practices by the peptide makers or packagers. Some risk exists there, but I have not seen much evidence that harm has frequently resulted, apart from the 7 cases of liver toxicity in Australia linked to contaminated reta. Misdosing can mostly be prevented by carefully checking and rechecking dilution and dose calculations, though mistakes are very easy to make. Receiving the wrong peptide does happen — getting selank instead of elora recently is unlikely to cause serious long-term issues — but at least one person in italy fell into a hypoglycaemic coma from insulin labelled as semaglutide, so it can occur, though it is not common from reputable sources.
All in all, the sharp reduction in risk of serious common health problems from the drug itself is at least 1 and possibly 2 orders of magnitude greater than the risks from grey sourced GLP peptides. That trade-off is nowhere near as clear-cut for the non GLP peptides, which may or may not carry long-term risks from the peptide itself.
With the grey versions in particular, the worries center on contaminants, whether toxic or carcinogenic, on peptide fragments, or on bacterial or fungal contamination. Mislabelling and misdosing are the other concerns. Infections from grey peptide use appear quite uncommon on this forum. From what I have read, peptide breakdown fragments are unlikely to be a problem because they have a very short half-life in the body; that leaves toxic residue from poor manufacturing or cleaning practices by the peptide makers or packagers. Some risk exists there, but I have not seen much evidence that harm has frequently resulted, apart from the 7 cases of liver toxicity in Australia linked to contaminated reta. Misdosing can mostly be prevented by carefully checking and rechecking dilution and dose calculations, though mistakes are very easy to make. Receiving the wrong peptide does happen — getting selank instead of elora recently is unlikely to cause serious long-term issues — but at least one person in italy fell into a hypoglycaemic coma from insulin labelled as semaglutide, so it can occur, though it is not common from reputable sources.
All in all, the sharp reduction in risk of serious common health problems from the drug itself is at least 1 and possibly 2 orders of magnitude greater than the risks from grey sourced GLP peptides. That trade-off is nowhere near as clear-cut for the non GLP peptides, which may or may not carry long-term risks from the peptide itself.
Seasonal1
Explorer
My only real concern is that access could disappear. Right now, in America, the political climate happens to favor peptides, but money talks.